chrX-12886851-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000380659.4(TLR7):c.1343C>T(p.Ala448Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00416 in 1,208,256 control chromosomes in the GnomAD database, including 24 homozygotes. There are 1,602 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000380659.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLR7 | NM_016562.4 | c.1343C>T | p.Ala448Val | missense_variant | 3/3 | ENST00000380659.4 | NP_057646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLR7 | ENST00000380659.4 | c.1343C>T | p.Ala448Val | missense_variant | 3/3 | 1 | NM_016562.4 | ENSP00000370034 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 317AN: 111780Hom.: 1 Cov.: 23 AF XY: 0.00209 AC XY: 71AN XY: 33992
GnomAD3 exomes AF: 0.00290 AC: 525AN: 181053Hom.: 3 AF XY: 0.00270 AC XY: 180AN XY: 66687
GnomAD4 exome AF: 0.00429 AC: 4708AN: 1096425Hom.: 23 Cov.: 32 AF XY: 0.00423 AC XY: 1531AN XY: 361869
GnomAD4 genome AF: 0.00283 AC: 317AN: 111831Hom.: 1 Cov.: 23 AF XY: 0.00208 AC XY: 71AN XY: 34053
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | TLR7: BP4, BS1, BS2 - |
TLR7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 04, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at